Russell Investments Group
RLAY icon

Russell Investments Group’s Relay Therapeutics RLAY Stock Holding History

Russell Investments Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.8M Buy
363,523
+346,683
+2,059% +$5.03M 0.01% 1308
2026
Q1 		$168K Buy
16,840
+4,378
+35% +$39.2K ﹤0.01% 2901
2025
Q4 		$105K Buy
12,462
+23
+0.2% +$164 ﹤0.01% 3038
2025
Q3 		$64.9K Sell
12,439
-7,670
-38% -$29.2K ﹤0.01% 3175
2025
Q2 		$69.6K Sell
20,109
-19,410
-49% -$57.7K ﹤0.01% 2907
2025
Q1 		$104K Sell
39,519
-40,285
-50% -$158K ﹤0.01% 2745
2024
Q4 		$329K Buy
79,804
+68,559
+610% +$373K ﹤0.01% 2397
2024
Q3 		$79.6K Sell
11,245
-8,182
-42% -$61.1K ﹤0.01% 2704
2024
Q2 		$127K Sell
19,427
-160,545
-89% -$1.1M ﹤0.01% 2577
2024
Q1 		$1.49M Buy
179,972
+65,484
+57% +$639K ﹤0.01% 1802
2023
Q4 		$1.26M Buy
114,488
+108,355
+1,767% +$914K ﹤0.01% 1853
2023
Q3 		$51.6K Buy
6,133
+3,033
+98% +$32.6K ﹤0.01% 2749
2023
Q2 		$38.9K Buy
+3,100
New +$38.6K ﹤0.01% 2756
2022
Q1 		– Sell
-871
Closed -$26K – 2898
2021
Q4 		$26K Hold
871
– – ﹤0.01% 2939
2021
Q3 		$27K Buy
+871
New +$29.3K ﹤0.01% 2981
2021
Q2 		– Sell
-30,134
Closed -$1.04M – 3282
2021
Q1 		$1.04M Buy
+30,134
New +$1.31M ﹤0.01% 2229

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Russell Investments Group's RLAY Position: Q2 2026 in Review

Russell Investments Group increased its Relay Therapeutics (RLAY) stake by 2,059% in Q2 2026, buying an estimated $5.03M and bringing the position to 363,523 shares worth $6.8M. The position accounts for 0.01% of the portfolio, ranked #1308.

Russell Investments Group first reported a position in RLAY in Q1 2021 and has held it in 16 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Russell Investments Group held 363,523 shares of Relay Therapeutics worth $6.8M as of Q2 2026.
  • Russell Investments Group bought 346,683 Relay Therapeutics shares in Q2 2026, an estimated $5.03M.
  • Relay Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1308 holding.
  • Russell Investments Group first reported a position in Relay Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.